Want to join the conversation?
In 2015, $MCO's MIS segment revenue grew 3% versus 2014, helped by benefits from changes in the mix of fee type and new fee initiatives. MA revenue grew 8% versus 2014, reflecting growth in ERS and RD&A. Excluding impact from unfavorable changes in FX rates, MIS revenue grew 8% and MA revenue grew 12%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)